Tablet containing dehydroepiandrosterone (dhea)
AssigneePantarhei Bioscience B. V.
InventorsHerman Jan Tijmen Coelingh Bennink, Johannes Jan Platteeuw
Life of this patent
Estimating the term…
Abstract
The present invention relates to a tablet having a weight of 30-200 mg and consisting of: 60-100 wt. % of granules consisting of: 50-90% by weight of the granules of dehydroepiandrosterone (DHEA); 6-35% by weight of the granules of microcrystalline cellulose; 0-20% by weight of the granules of one or more other pharmaceutically acceptable granule ingredients; and 0-40 wt. % of one or more other pharmaceutically acceptable tablet components. These tablets can suitably be used to orally administer DHEA in dosages of around 50 mg and are sufficiently small to be incorporated in, for instance, ordinary oral contraceptive blister packs.
Claims21
1-15. (canceled)
A tablet having a weight of 30-200 mg and consisting of:
- (a) 60-100 wt. % of granules consisting of:
- (i) 50-90% by weight of the granules of dehydroepiandrosterone (DHEA);
- (ii) 6-35% by weight of the granules of microcrystalline cellulose;
- and
- (iii) 0-20% by weight of the granules of one or more other pharmaceutically acceptable granule ingredients;
- and
- (b) 0-40 wt. % of one or more other pharmaceutically acceptable tablet components.
Dependencies are inferred from the claim text.